At a glance
ClinicalIndex Comparison RecordN/ACompleted· 7 enrolled
Drug / intervention
Stereotactic Body Radiotherapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized Phase II Study of Surgery With or Without Adjuvant Stereotactic Body Radiotherapy (SBRT) in Patients With Previously-Irradiated Head and Neck Cancer
In Brief
A clinical study evaluating Stereotactic Body Radiotherapy for Head and Neck Cancer. Completed, enrolled 7 participants across 1 site.
Detailed Summary
Comparison of patients with operable, recurrent previously-irradiated squamous cell head-and-neck cancers with or without adjuvant SBRT.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartAug 2015
First PostedAug 2015
Primary CompletionMay 2019
Study CompletionAug 2021
TodayJul 2026
First PostedAug 6, 2015
Enrollment StartAug 1, 2015
Primary CompletionMay 30, 2019
Study CompletionAug 6, 2021
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.9 years ago
Interventions
Stereotactic Body Radiotherapyradiation
Radiation